Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) Change in Accured Expenses (2016 - 2025)

Vycor Medical has reported Change in Accured Expenses over the past 16 years, most recently at -$103247.0 for Q4 2025.

  • Quarterly Change in Accured Expenses fell 963.7% to -$103247.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$67346.0 through Dec 2025, down 239.92% year-over-year, with the annual reading at -$67346.0 for FY2025, 239.92% down from the prior year.
  • Change in Accured Expenses was -$103247.0 for Q4 2025 at Vycor Medical, down from $12098.0 in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $44220.0 in Q2 2024 and troughed at -$103247.0 in Q4 2025.
  • The 5-year median for Change in Accured Expenses is $11168.5 (2022), against an average of $5191.3.
  • Year-over-year, Change in Accured Expenses surged 12266.67% in 2024 and then tumbled 963.7% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at $3303.0 in 2021, then surged by 595.82% to $22983.0 in 2022, then rose by 6.87% to $24563.0 in 2023, then tumbled by 51.33% to $11954.0 in 2024, then tumbled by 963.7% to -$103247.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Change in Accured Expenses are -$103247.0 (Q4 2025), $12098.0 (Q3 2025), and $11968.0 (Q2 2025).